We previously reported that activator protein-1 (AP-1), containing c-
Introduction
Balloon injury of artery results in the significant vascular intimal thickening, which is caused by various events, including vascular smooth muscle cell (SMC) proliferation and migration, and the accumulation of extracellular matrix. [1] [2] [3] Accumulating evidence indicates that intimal thickening by balloon injury is regulated by the complex interaction among a variety of growth-regulatory molecules, such as growth factors, vasoactive peptides, inflammatory cytokines or chemokines, etc, and these molecules are therefore regarded as the useful target for treatment of vascular thickening. 4, 5 On the other hand, as reviewed, [6] [7] [8] recent experimental evidence supports the fact that critical intracellular signaling molecules common to the induction and action of these growth-regulatory molecules, such as cdc2 kinase, proliferating-cell nuclear antigen, retinoblastoma protein RB, cyclin kinase inhibitor protein p21 or ras gene, etc, are useful targets for prevention of vascular hyperplasia, and targeting these intracellular signaling molecules is pro-
of DN-c-Jun was examined on balloon injury-induced intimal hyperplasia in rats. Before balloon injury, DN-c-Jun was transfected into rat carotid artery using the hemagglutinating virus of Japan-liposome method. In vivo transfection of DNc-Jun significantly inhibited vascular SMC proliferation in the intima and the media and subsequently prevented intimal thickening at 14 days after balloon injury. We obtained the first evidence that DN-c-Jun gene transfer prevented vascular SMC proliferation in vitro and in vivo, and c-Jun was involved in balloon injury-induced intimal hyperplasia. Thus, AP-1 seems to be the new therapeutic target for treatment of vascular diseases. Gene Therapy (2001) 8, 1682-1689.
posed to be more effective for treatment of vascular diseases than targeting growth-regulatory molecules.
Activator protein-1 (AP-1), a transcription factor, is commonly activated by vascular remodeling-related molecules, and plays a central role in the initiation of cellular responses, including cellular gene expression, growth, migration or apoptosis. 9, 10 Recently, AP-1 has been reported to be rapidly activated in balloon-injured artery and this activated AP-1 contained c-Jun, 11 and similar findings have been also obtained by our recent work. 12 Furthermore, in rats, vascular AP-1, composed of c-Jun, is also significantly activated in vivo by acute hypertension or angiotensin II administration. 13, 14 However, the significance of AP-1 for vascular diseases remains to be defined, mainly because of the lack of the specific and potent pharmacological inhibitor of AP-1.
In the present study, we examined the role of AP-1 in vascular smooth muscle cell (SMC) proliferation in vivo and in vitro, using gene transfer techniques of dominantnegative mutant of c-Jun (DN-c-Jun). We obtained the first evidence that AP-1 is directly involved in vascular SMC proliferation and neointimal formation after balloon injury.
Results

Characteristics of AP-1 DNA binding activity induced by Ad-DN-c-Jun infection
As indicated by gel mobility shift analysis in Figure 1a , Ad-DN-c-Jun infection increased AP-1 DNA binding activity. However, the position of AP-1 band due to Ad-DN-c-Jun was above that of endogenous AP-1 band induced by serum stimulation. As shown in Figure 1b , this band due to Ad-DN-c-Jun was found to be specific binding for AP-1, because the addition of unlabeled AP-1 oligonucleotides resulted in a decrease in the formation of AP-1 complexes in a dose-dependent manner, but the addition of excess amounts of unlabeled mutant AP-1 oligonuclotide did not affect the AP-1 complexes. Ad-Lac Z did not affect AP-1 DNA binding activity with or without serum stimulation. As shown by supershift analysis in Figure 1b Furthermore, to confirm the specific binding of DN-cJun to AP-1 consensus sequence, we also examined the H-thymidine incorporation in a dose-dependent manner, while AdLacZ at the same MOI did not affect at all (Figure 3a) . Ad-DN-c-Jun also inhibited serum-induced increase in cell number (Figure 3b) . However, the increase in SMC number by serum stimulation was not affected at all by Ad-LacZ.
Flow cytometric analysis in Figure 4 showed that Ad-DN-c-Jun significantly inhibited serum-induced S-phase entrance of SMC by 54%, whereas Ad-LacZ did not significantly affect it. Neither Ad-DN-c-Jun nor Ad-LacZ affected the percent of SMC in S phase, without serum stimulation.
Effects of DN-c-Jun on CDK2 activity
CDK2 activity was measured by the immune complex kinase assay using histone H1 as a substrate. As shown in Figure 5 , treatment of aortic SMC with 2% serum for 16 h induced the activation of CDK2 by two-fold (P Ͻ 0.01) and this activation was significantly and partially blocked by Ad-DN-c-Jun (P Ͻ 0.01), but not by Ad-LacZ. Ad-DN-c-Jun or Ad-LacZ did not affect the Cdk2 activity in aortic SMCs not subjected to serum stimulation.
Effects of DN-c-Jun gene transfer on neointimal formation after balloon injury
We examined the effect of DN-c-Jun gene transfer on intimal hyperplasia after balloon injury of rat carotid artery. Figure 6 indicates that DN-c-Jun was successfully expressed in the carotid artery subjected to in vivo DN- c-Jun gene transfer and subsequent endothelial denudation. As shown in Figure 7 , remarkable neointimal formation of carotid artery was observed in vehicle-transfected group at 14 days after balloon injury. DN-c-Jun gene transfer significantly decreased the intimal area and the I/M ratio, compared with vehicle (pUC-CAGGS) (0.84 ± 0.11 versus 1.22 ± 0.26; P Ͻ 0.01) at 14 days after injury.
As shown in Figure 8 , total intimal nuclei number per section in arterial segments transfected with DN-c-Jun was significantly smaller than that of vehicle-transfected arterial segment (1146 ± 73 versus 1808 ± 134; P Ͻ 0.01). The total medial nuclei number was also decreased by transfection with DN-c-Jun compared with that with vehicle (593 ± 30 versus 681 ± 28, P Ͻ 0.05).
Effects of DN-c-Jun in vivo gene transfer on smooth muscle cell proliferation and apoptosis after balloon injury
To estimate SMC proliferation, we measured the intimal and medial BrdU index at 7 days after balloon injury. As shown in Figure 9 , the significant proliferation of intimal SMC was observed by balloon injury, as shown by the significant increase in BrdU index. The percentages of BrdU-positive cells in the neointima from groups transfected with DN-c-Jun were smaller than that of vehicle group (25.1 ± 3.2% versus 36.9 ± 3.9%; P Ͻ 0.05). A small but significant increase in SMC proliferation was also seen in the media after balloon injury. The percentages of BrdU-positive cells in the media from groups transfected with DN-c-Jun were also smaller than that of vehicle group (2.9 ± 0.6% versus 8.6 ± 1.2%; P Ͻ 0.05).
The effect of DN-c-Jun on SMC apoptosis was examined at 7 days after balloon injury, because SMC apoptosis is reported to reach maximal levels at 7 days after injury. 15 There was no significant difference between vehicle-transfected and DN-c-Jun-transfected groups in TUNEL index of intima (35 ± 4% versus 32 ± 4%, respectively, n = 6), at 7 days after balloon injury. TUNEL index of media was negligible in either the vehicle-transfected or the DN-c-Jun-transfected group.
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Figure 5 Effects of Ad-DN-c-Jun on CDK2 activity in SMCs stimulated with or without serum. The phosphotransferase activity of Cdk2 was determined by protein kinase assay, immunoprecipitating with Cdk2 antibody and using histone H1 as substrate as described in detail in Materials and methods. Each value represents mean ± s.e.m. (n = 6).
Figure 6 Expression of DN-c-Jun in carotid artery subjected to in vivo gene transfer of DN-c-Jun. Total RNA was extracted from carotid arteries or cultured cells by the acid guanidinium thiocyanate-phenol-chloroform method. Expression of DN-c-Jun was determined by RT-PCR. RT-PCR was carried out with TaKaRa RNA PCR kit (AMV) Ver.2, according to the manufacturer's instructions. The samples underwent 30 cycles of denaturation (94°C), annealing (50°C), and extension (68°C)
.
Discussion
The major findings of our present work were that AP-1 is implicated in vascular SMC proliferation and intimal hyperplasia in the injured artery. As recently reviewed, AP-1 exerts diverse biological function including cell proliferation, transformation, differentiation and apoptosis, depending on the cell type and the context of other regulatory influences that the cell is receiving. [16] [17] [18] [19] AP-1 plays a critical role in proliferation of cultured fibrolasts and hepatoblasts, while overexpression of c-Jun, the component of AP-1, is shown to induce apoptosis in 3T3 fibroblasts and triggers apoptosis in vascular endothelial cells. 16 However, the biological role of AP-1 in vascular SMC remains to be determined. We and other groups of investigators have previously reported that AP-1-binding activity, composed of c-Jun, is significantly enhanced in injured rat artery by balloon angioplasty, the elevation of blood pressure, or angiotensin II infusion, [11] [12] [13] [14] suggesting that AP-1 containing c-Jun may play some role in various vascular diseases. These findings encouraged us to examine the role of AP-1 in vascular SMC proliferation and intimal hyperplasia in injured artery, by gene transfer of dominant negative mutant of c-Jun.
In the present in vitro study, we found that gene transfer of dominant negative c-Jun gene with adenoviral vector specifically suppressed endogenous AP-1 binding activity and promoter activity in vascular SMC, as shown by electrophoretic mobility shift assay and dual luciferase assay, showing that gene transfer of DN-c-Jun is the most useful method to block endogenous AP-1. Gene transfer of DN-c-Jun significantly inhibited serum-induced increase in 3 H-thymidine incorporation and cell number in vascular SMC, thereby providing the evidence that AP-1 is involved in vascular SMC proliferation in vitro. Furthermore, as shown by flow cytometric analysis and the inhibition of cdk2 activity, the inhibition of vascular SMC by DN-c-Jun is mediated by cell cycle arrest in G1 phase. On the other hand, LacZ gene transfer with adenoviral vector at the same MOI as DN-c-Jun did not affect AP-1 binding activity, AP-1 promoter activity, 3 H-thymidine incorporation, cell number, cell cycle or cdk2 activity in vascular SMC. Thus, in this study, the nonspecific effect of the adenoviral vector used is negligible.
To examine whether the inhibition of cultured vascular SMC proliferation by AP-1 inhibition with DN-c-Jun can apply to in vivo situation, we examined the effect of DNc-Jun gene transfer on intimal hyperplaisa in ballooninjured artery. To transfect this mutant gene into rat carotid artery we employed the HVJ-liposome technique, [20] [21] [22] [23] because the use of the HVJ-liposome method allows for effective gene transfer into medial SMC of the intact carotid artery not subjected to endothelial denudation. 24 Furthermore, successful gene transfer of DN-cJun in this study is supported by the findings that DNc-Jun was significantly expressed at least until 8 days after in vivo gene transfer (Figure 6 ), although the in vivo inhibition of AP-1 by DN-c-Jun was not examined in this study because of technical difficulties. Of note is the observation that DN-c-Jun gene transfer significantly suppressed neointimal hyperplasia in balloon-injured artery. Furthermore, the reduction of intimal area by DNc-Jun gene transfer was associated with a decrease in cell number or BrdU index in the intima, but not with apoptosis. Therefore, these observations demonstrate that the prevention of intimal hyperplasia by DN-c-Jun is at least in part mediated by the inhibition of vascular SMC proliferation. However, despite the suppression of SMC proliferation in the media by DN-c-Jun, the medial area was unchanged by DN-c-Jun. Although the present study did not allow us to explain this discrepancy, this may be explained by the fact that the medial area is also affected by medial accumulation of extracellular matrix or the migration of SMC from the media to the intima. Further study is needed to elucidate this point. Our work provided the first evidence that AP-1 is involved in SMC proliferation in injured artery in vivo as well as the proliferation of cultured vascular SMC in vitro. In this work, we did not examine the role of c-Fos, another major component of AP-1, because of the lack of the availability of the dominant negative form of c-Fos. Therefore, the effect of AP-1 blockade by dominant negative c-Fos remains to be determined.
As in the case of most previous studies concerning the effects of in vivo gene transfer with adenovirus vector or HVJ/liposome on arterial hyperplasia, 6 in this work, the duration of isolation of the arterial segment for gene transfer was longer than that accepted in the clinical situation. Therefore, the development of more effective gene transfer techniques is essential for clinical application. Furthermore, arterial restenosis in humans after balloon injury generally occurs at longer periods than in rats. Thus, further study is needed to determine whether our present findings can apply to human restenosis.
In conclusion, we obtained the first evidence that specific blockade of AP-1 by dominant negative c-Jun gene transfer prevents SMC proliferation and neointimal thickening in balloon-injured artery, demonstrating that AP-1 triggers a series of molecular events leading to neointimal hyperplasia in vivo. Thus, our work provided a new insight into the molecular mechanism of neointimal hyperplasia. AP-1 is probably the new useful therapeutic target for the prevention of vascular diseases.
Materials and methods
Preparation of SMC
Rat aortic SMC were prepared from thoracic aortas of male Sprague-Dawley rats by using the collagenase digestion method and cultured, as described. 25 For all experiments, rat aortic SMC from passages 4 to 7 were used. SMC were grown to 70-80% confluence and then made quiescent by incubation with DMEM containing 0.1% FBS for 48 h before addition of 2% serum.
Construction of recombinant adenovirus containing the dominant negative mutant of c-Jun
The dominant negative mutant of c-Jun, called TAM67, was generated by lacking transactivational domain of amino acid from 3 to 122 of wild c-Jun with polymerase chain reaction.
26 TAM67 has the DNA-binding domain of wild c-Jun. Recombinant replication-defective E1-and E3-adenoviral vectors expressing TAM67 gene (Ad-DNc-Jun) were constructed using adenovirus expression vector kit (TAKARA Biomedicals, Japan), according to the Gene Therapy method of Miyake et al. 27 cDNA encoding TAM67 was placed into a cassette cosmid vector PaxCAwt which possesses CAG promoter comprising a cytomegalovirus enhancer, chicken ␤-actin promoter and rabbit ␤-globin poly A signal. A recombinant adenovirus was constructed by in vitro homologus recombination in 293 cells using the above cosmid vector PaxCAwt containing TAM67 cDNA and the adenovirus DNA-terminal protein complex. Recombinant adenoviruses containing bacterial ␤-galactosidase gene (Ad-LacZ) were also constructed as the negative control of Ad-DN-c-Jun, in the same way as Ad-DN-c-Jun. The titer of the virus was determined by limiting dilution in 293 cells and expressed as plaqueforming units (p.f.u.).
Adenovirus-mediated gene transfer to SMC
In vitro gene transfer to aortic SMCs was carried out by incubation with the adenoviral vector with multiplicity of infection (MOI) of 20 or 200 MOI in D-MEM containing 0.1% FBS for 1 h at 37°C, 5% CO 2 and 95% air. Then, SMCs were made quiescent for 48 h before being assessed for the expression and the effect of the transferred gene.
Measurement of DNA synthesis and cell growth
SMCs in six-well plates were stimulated by 2% serum for 19 h and pulsed with 1 Ci/ml 3 H-thymidine for 5 h. Then cells were washed twice with PBS, incubated for 5 min in 5% trichloroacetic acid, washed with methanol, and dissolved in 99% formic acid. The incorporation of 3 H-thymidine into trichloroacetic acid-insoluble material was measured by liquid scintillation spectrophotometer.
For the assay of cell growth, SMCs in 60-mm plates were stimulated by 2% serum, and the cell number was counted by Coulter counter (Beckman) on various days.
Western blot analysis
Western blot analysis was carried out, as described in detail. 12 SMCs were harvested by scraping with lysis buffer, sonicated, centrifuged to obtain the supernatant, and stored at Ϫ80°C until use. Antibodies against c-Jun (sc-44; Santa Cruz, Santa Cruz, CA, USA) (1:10 000) were used for the detection of DN-c-Jun protein.
Electrophoretic mobility shift assay
For DNA protein-binding reaction, electrophoretic mobility shift assay was performed as described in detail.
14 The sequence of double-stranded consensus oligonucleotides of AP-1, NF-kappa B, SRE and Sp1 was previously described. Supershift assay was performed with rabbit polyclonal anti-c-Fos IgG (sc-253-G, 2 g), anti-c-Jun IgG (sc-822X, 2 g) recognizing the amino acid from 56 to 69 (transactivation domain) of wild c-Jun, or anti-c-Jun IgG (sc-44X, 2 g) recognizing the conserved DNA binding domain of wild c-Jun (all from Santa Cruz).
Dual luciferase assay
The vectors used in dual luciferase assay were purchased from Clontech (Palo Alto, CA, USA; Mercury pathway profiling luciferase system K2049-1). The specific cis-acting DNA binding sequence of vectors is located upstream from the TATA-like promoter region from the herpes simplex virus thymidine kinase (HSKtk) promoter that provides optimal induction of the reporter. SMCs in 24-well culture dishes (Corning, Corning, NY, USA) were transfected with 0.4 g of pAP1-Luc vector, pNF-kappaB-Luc vector, or pSRE-Luc vector, which were co-transfected with 0.1 g of pRL-TK vector (Toyo Inki, Japan), a vector that contains seapangy reporter gene. Gene transfections were performed using the LipofectAMINE PLUS Reagent (Life Technologies, Gaithersburg, MD, USA). After 24-h incubation in DMEM containing 0.1% FBS, cells were infected with Ad-DN-c-Jun or Ad-LacZ and then starved for another 24 h. Cells were harvested in cell lysis buffer and luciferase activities were assayed according to the Picagene dual seapangy user manual (PG-DUAL-SP) (Toyo Inki). For the correction of the difference in transfection efficiency among dishes, final luciferase activity of an individual dish was divided by its seapangy-luciferase.
Flow cytometric analysis
Cells were trypsinized, washed twice with PBS, and fixed in 70% ethanol at Ϫ20°C. Before measurement, fixed cells were centrifuged at 3000 r.p.m. for 5 min and resuspended in dye combination containing 50 g/ml RNase and 25 g/ml propidium iodide (PI) (Sigma, St Louis, MO, USA) for DNA staining. Cellular DNA content was assessed by FACS flow cytometer (Becton Dickinson, Mountain View, CA, USA). The DNA histogram analysis of cell distribution was measured by using ModFitLT software (Verita).
Protein kinase assay
The phosphotransferase activity of cyclin-dependent kinase (Cdk)2 was determined by immune complex kinase assay using histone H1 as substrate. Lysate proteins (150 g) were subjected to immunoprecipitaion with 1 g of anti-Cdk2 antibody (sc-163; Santa Cruz) absorbed to protein A-Sepharose beads for 24 h at 4°C. The immune complexes were washed three times with Triton X-100 lysis, and twice with kinase assay buffer (20 mm Hepes, pH 7.4, 5 mm MgCl 2 , 1 mm dithiothreitol). Histione H1 kinase activity was initiated by resuspending the beads in a volume of 30 l of kinase assay buffer containing 0.25 mg/ml histone H1 (Boehringer Mannheim, Japan), 100 m ATP, and 10 Ci ␥-32 P-ATP at 30°C for 5 min, stopped by addition of 2 × loading sample buffer, and then subjected to electrophoresis on 12% acrylamide gels. Bioimaging analyzer (BAS-5000, Fuji, Japan) was used for measurement of autoradiographs.
In vivo gene transfer of DN-c-Jun and balloon injury
The DN-c-Jun was ligated into the blunted EcoRI site of pUC-CAGGS expression plasmid. The pUC-CAGGS vector lacking cDNA served as control vector (vehicle). The preparation of HVJ-liposomes has been previously described in detail. 20, 21, 23 All procedures were in accordance with institutional guidelines for animal research. Nine-to 10-week-old male Sprague-Dawley rats (Clea Japan, Tokyo, Japan), weighing approximately 300-350 g, were used in the present study. Rats were anesthetized with sodium pentobarbital (40 mg/kg, i.p.). The left common carotid artery 20 mm proximal to the carotid bifurcation and the left internal carotid artery at the orifice were temporary occluded by aneurysmal clips. The external carotid artery was ligated at the exposed distal end. To achieve in vivo gene transfer, the common carotid artery segment was isolated by temporary clips. An infusion cannula was introduced into the segment of the common carotid artery through a small window opened in the external carotid artery. The HVJ-liposome complex with pUC/DN-c-Jun or pUC-CAGGS vector as control was infused into the closed luminal segment of common carotid artery and incubated for 15 min at room temperature, as previously reported. 20, 21, 23 After incubation, the infused fluid of HVJ-liposome complex was removed, the external carotid artery was ligated at the orifice, the blood flow to the common and internal carotid arteries was restored by releasing the clips, and the wound was closed. At 2 days after gene transfer, the endothelial denudation of the left common carotid artery was carried out by three passages of a Fogarty 2F balloon catheter (Baxter Healthcare, Deerfield, IL, USA) through the left femoral artery, as previously described.
12,28
Measurement of ratio of intimal/medial areas
For the estimation of ratio of intimal/medial areas (I/M ratio), at 14 days after balloon injury, rats were anesthetized with ether, and carotid arteries were fixed by perfusion of 10% (wt/vol) formaldehyde for 15 min under constant pressure, removed, embedded in paraffin and sectioned at 3 m thickness. Cross-sections were stained with Elastica Van Gieson, and hematoxylin and eosin. The intimal and the medial areas of each cross-section were measured with a light microscope connected to the image analyzer, and the I/M ratio was calculated.
BrdU immunohistochemistry, TUNEL index and morphometric analyses
We measured the percentages of BrdU-positive cells at 7 days after injury, as previously reported. 29 In brief, for BrdU immunohistochemistry, rats were i.p. injected with 100 mg/kg BrdU at 24 and 1 h before death. The left carotid arteries were fixed by perfusion of 10% (wt/vol) formaldehyde for 15 min, removed, embedded in paraffin and sectioned at 3 m thickness. BrdU immunohistochemistry was performed with a mouse anti-BrdU monoclonal antibody (Amersham, Japan) and LSAB2 kit (DAKO Japan).
Apoptotic cells were detected by the terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end-labeling (TUNEL) method using Apop Tag (Intergen, USA), according to the manufacturer's instructions. 15 The counterstain was done with 0.5% methyl green. A negative control was incubated without the TdT. To quantify apoptosis, the percentage of apoptotic cells in the total cell population (TUNEL index) was calculated by counting all cells from five random microscopic fields at a magnification of ×200.
Total nuclei number of the intima and media at 14 days after injury was estimated for each section by multiplying the intimal and medial cross-sectional areas, respectively, as previously described. 29 
Statistical analysis
All data are presented as mean ± s.e.m. Statistical significance was determined with one-way analysis of variance (ANOVA) and Duncan multiple range test. Differences were considered statistically significant at a value of P Ͻ 0.05.
